Ridogrel

Ridogrel is a dual action drug useful for the prevention of systemic thrombo-embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial infarction. However, there currently are no clinical indications for preferential use of ridogrel over aspirin. It is grouped under the following drug class(es): Antiplatelets. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Ridogrelum, Ibidel and R-68070. Its PubChem CID is 5362391.

CAS No 110140-89-1
Molecular Formula C18H17F3N2O3
Molecular Weight 366.3 g/mol
Synonyms 5-[(E)-[pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypentanoic acid

Frequently Asked Questions